Combination therapy not necessary to achieve remission in breast cancer patients with HER-2-positive disease

Giving trastuzumab and anthracyclines at the same time is effective at treating HER-2-positive breast cancer, but there is concern that this combination can be associated with an increased risk of cardiac toxicity.
Source: M. D. Anderson Cancer Center - News Releases - Category: Cancer & Oncology Source Type: news